MATINAS BIOPHARMA HOLDINGS, INC. Class of Warrant or Right, Outstanding
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Class of Warrant or Right, Outstanding of 9.29 million shares as of 2017-01-13, per its 10-Q filed 2017-05-15.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2017-05-15
- 2017-01-13: Class of Warrant or Right, Outstanding 9.29M shares.
- 2016-12-31: Class of Warrant or Right, Outstanding 40.26M shares.
- 2016-12-14: Class of Warrant or Right, Outstanding 31.00M shares.
- 2016-09-30: Class of Warrant or Right, Outstanding 40.52M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2017-01-13 | 9.29M shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 40.26M shares 10-K · filed 2017-03-31 |
| 2016-12-14 | 31.00M shares 10-K · filed 2017-03-31 |
| 2016-09-30 | 40.52M shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 39.25M shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 39.25M shares 10-Q · filed 2016-05-13 |
| 2015-12-31 | 39.25M shares 10-K · filed 2017-03-31 |
| 2015-09-30 | 39.25M shares 10-Q · filed 2015-11-10 |
| 2015-06-30 | 39.25M shares 10-Q · filed 2015-08-13 |
| 2015-03-31 | 27.10M shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 15.25M shares 10-K · filed 2017-03-31 |
| 2014-09-30 | 15.25M shares 10-Q · filed 2014-11-14 |
| 2014-06-30 | 15.25M shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 15.25M shares 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |